Table 2.
Items | MACE (+) (n = 26) | MACE (–) (n = 740) | Statistical values | P |
Demographics | ||||
Age (years) | 64.0 ± 7.3 | 62.7 ± 7.9 | –0.082∗ | 0.408 |
Male | 21 (80.8) | 629 (85.0) | 0.098† | 0.754 |
Symptomatic | 20 (76.9) | 466 (63.1) | 2.084† | 0.149 |
Hypertension | 16 (61.5) | 280 (37.8) | 1.038† | 0.308 |
Diabetes | 14 (53.8) | 229 (30.9) | 6.081† | 0.014 |
Hyperlipidemia | 19 (73.1) | 475 (64.2) | 0.866† | 0.352 |
CAD | 7 (26.9) | 134 (18.1) | 0.779† | 0.377 |
Smoking | 12 (46.2) | 395 (53.4) | 0.526† | 0.468 |
Drinking | 8 (30.8) | 264 (35.7) | 0.264† | 0.607 |
Stroke history | 10 (38.5) | 243 (32.8) | 0.359† | 0.549 |
Laboratory | ||||
BMI (kg/m2) | 24.48 ± 2.39 | 25.03 ± 3.37 | 0.825∗ | 0.410 |
SBP (mmHg) | 136.00 ± 16.59 | 134.29 ± 17.59 | –0.516∗ | 0.610 |
DBP (mmHg) | 76.92 ± 9.12 | 77.21 ± 10.31 | 0.142∗ | 0.887 |
Creatinine (μmol/L) | 72.15 ± 19.13 | 69.06 ± 16.97 | –0.909∗ | 0.363 |
Low HDL | 9 (34.6) | 306 (41.4) | 0.471† | 0.493 |
LDL (mmol/L) | 1.91 ± 0.70 | 1.99 ± 0.71 | 0.580∗ | 0.567 |
TC (mmol/L) | 3.45 ± 1.00 | 3.48 ± 0.87 | 0.148∗ | 0.883 |
TG (mmol/L) | 1.66 ± 1.00 | 1.52 ± 0.88 | –0.827∗ | 0.408 |
FBG (mmol/L) | 6.22 ± 2.12 | 5.75 ± 1.65 | –1.399∗ | 0.162 |
MetS | 9 (34.6) | 117 (15.8) | 5.167† | 0.023 |
Imaging | ||||
Right side operation | 15 (57.7) | 387 (52.3) | 0.293† | 0.588 |
Calcified plaque | 7 (26.9) | 239 (32.3) | 0.333† | 0.564 |
Ulcerative plaque | 9 (34.6) | 159 (21.5) | 2.529† | 0.112 |
Stenosis degree | 85.04 ± 9.64 | 84.83 ± 10.13 | –0.106∗ | 0.916 |
Contralateral stenosis ≥70% | 5 (19.2) | 93 (12.6) | 0.492† | 0.483 |
t values.
Chi-squared values.
Data are shown as mean ± standard deviation or n (%). CEA: Carotid endarterectomy; MACEs: Major adverse clinical events; BMI: Body mass index; CAD: Coronary artery disease; SBP: Systolic blood pressure; DBP: Diastolic blood pressure, LDL: Low-density lipoprotein; HDL: High-density lipoprotein; TC: Total cholesterol; TG: Triglyceride; FBG: Fasting blood glucose; MetS: Metabolic syndrome.